Lv1
20 积分 2023-10-09 加入
Molecular glue degraders: exciting opportunities for novel drug discovery
1天前
待确认
Targeted protein degradation for cancer therapy
1天前
已完结
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation
19天前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
1个月前
已完结
Advancing engineering design strategies for targeted cancer nanomedicine
1个月前
已完结
Bioengineering strategies to optimize STING agonist therapy
1个月前
已完结
FDA approves 100th small-molecule kinase inhibitor
1个月前
已完结
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
1个月前
已完结
Inhibitors and PROTACs of CDK2: challenges and opportunities
2个月前
已完结
Tissue-resident memory T cells at the center of immunity to solid tumors
2个月前
已完结
皖公网安备34019202002308
